Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00764634
Recruitment Status : Completed
First Posted : October 2, 2008
Last Update Posted : December 2, 2011
Sponsor:
Information provided by (Responsible Party):
DynPort Vaccine Company LLC, A GDIT Company

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2010
Actual Study Completion Date : December 2010
Certification/Extension First Submitted : June 29, 2011